Cambridge Investment Research Advisors
RVNC

Cambridge Investment Research Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History

Cambridge Investment Research Advisors’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-6,981
Closed -$225K – 3315
2023
Q1 		$225K Buy
+6,981
New +$225K ﹤0.01% 2731